Cargando…
Regulation of RIP3 by the transcription factor Sp1 and the epigenetic regulator UHRF1 modulates cancer cell necroptosis
Receptor-interacting kinase-3 (RIP3) is a key regulator of necroptosis. It has been shown that the expression of RIP3 is silenced in most cancer cells and tissues due to genomic methylation. However, the regulatory mechanisms controlling RIP3 expression in cancer cells have not been fully elucidated...
Autores principales: | Yang, Chengkui, Li, Jun, Yu, Lu, Zhang, Zili, Xu, Feng, Jiang, Lang, Zhou, Xiuxia, He, Sudan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5682651/ https://www.ncbi.nlm.nih.gov/pubmed/28981102 http://dx.doi.org/10.1038/cddis.2017.483 |
Ejemplares similares
-
RIP1/RIP3-regulated necroptosis as a target for multifaceted disease therapy (Review)
por: Liu, Yuping, et al.
Publicado: (2019) -
Epigenetic Regulation of RIP3 Suppresses Necroptosis and Increases Resistance to Chemotherapy in NonSmall Cell Lung Cancer
por: Wang, Qiong, et al.
Publicado: (2019) -
The RIP1–RIP3 Complex Mediates Osteocyte Necroptosis after Ovariectomy in Rats
por: Cui, Hongwang, et al.
Publicado: (2016) -
Necroptosis regulates tumor repopulation after radiotherapy via RIP1/RIP3/MLKL/JNK/IL8 pathway
por: Wang, Yiwei, et al.
Publicado: (2019) -
RIP3-mediated necroptosis is regulated by inter-filament assembly of RIP homotypic interaction motif
por: Hu, Hong, et al.
Publicado: (2020)